file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | REVIEW | 11 | 60 | 172 |
| 202 | BLOCK | 5 | 59 | 92 |
| 203 | CUTTING | 1 | 59 | 75 |
| 204 | EDGE | 1 | 59 | 75 |
| 205 | LEUKOCYTES | 12 | 59 | 259 |
| 206 | NEONATAL | 10 | 59 | 131 |
| 207 | INVESTIGATIVE | 1 | 57 | 100 |
| 208 | MINOR | 14 | 57 | 241 |
| 209 | PANCREATIC | 5 | 57 | 197 |
| 210 | INFUSION | 17 | 56 | 182 |
| 211 | TERMINATION | 3 | 56 | 71 |
| 212 | ANTI-CD4 | 4 | 55 | 169 |
| 213 | CELL-FREE | 5 | 55 | 152 |
| 214 | CHRONIC | 17 | 55 | 364 |
| 215 | DENDRITIC | 20 | 55 | 586 |
| 216 | HEMORRHAGE | 2 | 55 | 106 |
| 217 | HEPATOCYTES | 6 | 55 | 758 |
| 218 | MOTHERS | 5 | 55 | 61 |
| 219 | ORGAN-TRANSPLANTATION | 2 | 55 | 211 |
| 220 | PEDIATRIC | 17 | 55 | 83 |
| 221 | PERMITTED | 2 | 55 | 211 |
| 222 | POSSIBLE | 7 | 55 | 128 |
| 223 | VIEW | 2 | 55 | 211 |
| 224 | HLA-SPECIFIC | 3 | 54 | 62 |
| 225 | ISLET | 11 | 54 | 119 |
| 226 | LIVING | 15 | 54 | 565 |
| 227 | PAROUS | 7 | 54 | 69 |
| 228 | WHITE | 7 | 54 | 186 |
| 229 | ADVANCED | 9 | 53 | 93 |
| 230 | ASSESSMENT | 7 | 53 | 76 |
| # | Word | Recs | TLCS | TGCS |
| 231 | BREAST | 11 | 53 | 101 |
| 232 | CD8 | 13 | 53 | 253 |
| 233 | FISH | 6 | 53 | 129 |
| 234 | GRAFTS | 12 | 53 | 191 |
| 235 | PHARMACOLOGICAL | 1 | 53 | 202 |
| 236 | PHENOTYPE | 6 | 53 | 167 |
| 237 | SCIENCES | 1 | 53 | 202 |
| 238 | TRENDS | 1 | 53 | 202 |
| 239 | NATURAL | 9 | 52 | 120 |
| 240 | PARAFFIN-EMBEDDED | 3 | 52 | 70 |
| 241 | SECTIONS | 2 | 52 | 70 |
| 242 | CLONAL | 3 | 51 | 166 |
| 243 | PCR | 33 | 51 | 106 |
| 244 | COMPLEX | 5 | 50 | 89 |
| 245 | MAJOR | 6 | 50 | 86 |
| 246 | MALIGNANCIES | 9 | 50 | 108 |
| 247 | NON-T-CELL-DEPLETED | 11 | 50 | 88 |
| 248 | NOVEL | 7 | 50 | 164 |
| 249 | PRESENT | 3 | 50 | 102 |
| 250 | REMODELING | 1 | 50 | 54 |
| 251 | HEMATOLYMPHOID | 3 | 49 | 151 |
| 252 | HYPOREACTIVITY | 5 | 49 | 81 |
| 253 | MISMATCHED | 12 | 49 | 97 |
| 254 | PERSISTENCE | 12 | 49 | 130 |
| 255 | PROFILE | 2 | 49 | 73 |
| 256 | RETROVIRUS | 14 | 49 | 674 |
| 257 | BETA | 6 | 48 | 91 |
| 258 | CONGENITAL | 3 | 48 | 64 |
| 259 | LACK | 8 | 48 | 130 |
| 260 | MULTI-LINEAGE | 1 | 48 | 68 |
| # | Word | Recs | TLCS | TGCS |
| 261 | MYOCARDIAL-TISSUE-SPECIFIC | 1 | 48 | 56 |
| 262 | REVERSE | 2 | 48 | 72 |
| 263 | SPECIFIC | 25 | 48 | 234 |
| 264 | ALLELES | 14 | 47 | 102 |
| 265 | KINETICS | 5 | 47 | 118 |
| 266 | RELEVANCE | 8 | 47 | 126 |
| 267 | SONS | 2 | 47 | 53 |
| 268 | DONOR-RECIPIENT | 5 | 46 | 92 |
| 269 | FEMALES | 5 | 46 | 54 |
| 270 | NONINVASIVE | 1 | 46 | 87 |
| 271 | PROSPECTIVE | 12 | 46 | 156 |
| 272 | UNRESPONSIVENESS | 4 | 46 | 164 |
| 273 | APPROACH | 7 | 45 | 170 |
| 274 | FETUS | 11 | 45 | 100 |
| 275 | GVH | 1 | 45 | 120 |
| 276 | HIGH | 11 | 45 | 106 |
| 277 | REACTIONS | 4 | 45 | 135 |
| 278 | SITU | 8 | 45 | 85 |
| 279 | DIFFERENTIATION | 4 | 44 | 738 |
| 280 | SUCCESSFUL | 11 | 44 | 68 |
| 281 | CORRELATION | 8 | 43 | 50 |
| 282 | FUNCTION | 11 | 43 | 147 |
| 283 | INCIDENTAL | 3 | 43 | 77 |
| 284 | PASSENGER | 9 | 43 | 187 |
| 285 | PIG | 9 | 43 | 648 |
| 286 | REACTIVE | 3 | 43 | 65 |
| 287 | RESPONSE | 12 | 43 | 85 |
| 288 | TH2-ORIENTED | 1 | 43 | 65 |
| 289 | ALLOANTIGENS | 5 | 42 | 249 |
| 290 | ANERGY | 1 | 42 | 138 |
| # | Word | Recs | TLCS | TGCS |
| 291 | CERVICAL | 2 | 42 | 45 |
| 292 | DERIVED | 8 | 42 | 154 |
| 293 | LYMPHOID | 7 | 42 | 98 |
| 294 | NEWBORN | 2 | 42 | 54 |
| 295 | OUTCOME | 20 | 42 | 281 |
| 296 | RENAL-TRANSPLANT | 1 | 42 | 138 |
| 297 | SEQUENCE-SPECIFIC | 6 | 42 | 58 |
| 298 | T-LYMPHOCYTE | 1 | 42 | 138 |
| 299 | TREATED | 4 | 42 | 569 |
| 300 | BIRTH | 12 | 41 | 96 |
| 301 | GAUCHERS-DISEASE | 1 | 41 | 159 |
| 302 | GLYCOGEN-STORAGE-DISEASE | 1 | 41 | 159 |
| 303 | MAY | 10 | 41 | 74 |
| 304 | TYPE-1 | 1 | 41 | 159 |
| 305 | TYPE-IV | 1 | 41 | 159 |
| 306 | BARRIER | 3 | 40 | 69 |
| 307 | BRAIN | 3 | 40 | 93 |
| 308 | COMBINED | 15 | 40 | 225 |
| 309 | DISORDERS | 6 | 40 | 53 |
| 310 | LESIONS | 4 | 40 | 46 |
| 311 | LOSS | 6 | 40 | 63 |
| 312 | SON | 2 | 40 | 43 |
| 313 | INDUCED | 22 | 39 | 313 |
| 314 | LEUKEMIA | 13 | 39 | 72 |
| 315 | ABLE | 1 | 38 | 57 |
| 316 | ACTIVITY | 4 | 38 | 52 |
| 317 | BLOOD-BRAIN | 1 | 38 | 57 |
| 318 | CROSS | 1 | 38 | 57 |
| 319 | FIBROSIS | 2 | 38 | 62 |
| 320 | FREQUENCY | 5 | 38 | 53 |
| # | Word | Recs | TLCS | TGCS |
| 321 | HEPATIC | 6 | 38 | 152 |
| 322 | IMPACT | 12 | 38 | 218 |
| 323 | MATERNAL-FETAL | 4 | 38 | 56 |
| 324 | MICROCHIMERISMS | 4 | 38 | 59 |
| 325 | NESTED | 9 | 38 | 48 |
| 326 | VIVO | 8 | 38 | 222 |
| 327 | ANTIBODY | 7 | 37 | 94 |
| 328 | CUTANEOUS | 2 | 37 | 41 |
| 329 | FLUORESCENCE | 7 | 37 | 75 |
| 330 | HEMATOLOGIC | 3 | 37 | 59 |
| 331 | HYBRIDIZATION | 3 | 37 | 50 |
| 332 | IMMUNOSUPPRESSION | 14 | 37 | 513 |
| 333 | LIVERS | 5 | 37 | 63 |
| 334 | MAINTENANCE | 6 | 37 | 114 |
| 335 | PARTICIPATE | 3 | 37 | 45 |
| 336 | REQUIRED | 4 | 37 | 87 |
| 337 | SHORT-TERM | 3 | 37 | 93 |
| 338 | SYSTEMATIC | 2 | 37 | 41 |
| 339 | CHLORIDE | 3 | 36 | 57 |
| 340 | CLASS | 10 | 36 | 127 |
| 341 | DERMAL | 1 | 36 | 46 |
| 342 | FACTOR | 7 | 36 | 127 |
| 343 | INDUCES | 8 | 36 | 388 |
| 344 | NUMBERS | 2 | 36 | 54 |
| 345 | PARITY | 12 | 36 | 84 |
| 346 | STATUS | 11 | 36 | 80 |
| 347 | VINYL | 2 | 36 | 47 |
| 348 | CLEAR | 1 | 35 | 74 |
| 349 | FAMILY | 7 | 35 | 79 |
| 350 | PRETREATMENT | 1 | 35 | 74 |
| # | Word | Recs | TLCS | TGCS |
| 351 | PRIMERS | 3 | 35 | 42 |
| 352 | ACQUIRED | 9 | 34 | 74 |
| 353 | CD34 | 10 | 34 | 83 |
| 354 | ENDOTHELIAL | 8 | 34 | 105 |
| 355 | MATE | 1 | 34 | 38 |
| 356 | MATERNALLY | 2 | 34 | 43 |
| 357 | OCCURS | 4 | 34 | 66 |
| 358 | PLACENTA | 5 | 34 | 165 |
| 359 | TRANSFUSED | 14 | 34 | 95 |
| 360 | DONOR-DERIVED | 14 | 33 | 235 |
| 361 | RHEUMATIC | 4 | 33 | 44 |
| 362 | STABLE | 5 | 33 | 76 |
| 363 | STATE | 3 | 33 | 56 |
| 364 | TUMOUR | 2 | 33 | 37 |
| 365 | ACTIVE | 5 | 32 | 74 |
| 366 | ACUTE | 20 | 32 | 131 |
| 367 | CONSEQUENCES | 4 | 32 | 59 |
| 368 | DAUGHTER | 2 | 32 | 38 |
| 369 | MICHROCHIMERISM | 1 | 32 | 51 |
| 370 | APHERESIS | 1 | 31 | 39 |
| 371 | CARDIAC | 23 | 31 | 346 |
| 372 | CD34-ENRICHED | 1 | 31 | 39 |
| 373 | CHILDREN | 12 | 31 | 51 |
| 374 | INTRATHYMIC | 14 | 31 | 267 |
| 375 | KIDNEYS | 4 | 31 | 51 |
| 376 | LOW-RATIO | 1 | 31 | 53 |
| 377 | PRODUCTS | 2 | 31 | 39 |
| 378 | PROLIFERATION | 2 | 31 | 55 |
| 379 | TRANSFUSION-ASSOCIATED | 14 | 31 | 150 |
| 380 | USE | 6 | 31 | 64 |
| # | Word | Recs | TLCS | TGCS |
| 381 | BIOPSIES | 5 | 30 | 45 |
| 382 | IMMUNITY | 13 | 30 | 134 |
| 383 | MACROPHAGES | 3 | 30 | 36 |
| 384 | PRETRANSPLANT | 6 | 30 | 63 |
| 385 | RHESUS | 5 | 30 | 208 |
| 386 | BYPRODUCT | 1 | 29 | 56 |
| 387 | CONNECTIVE | 1 | 29 | 31 |
| 388 | HLA-CW | 2 | 29 | 37 |
| 389 | IMMUNOFLUORESCENCE | 3 | 29 | 31 |
| 390 | OCCURRING | 2 | 29 | 35 |
| 391 | ORGAN-SPECIFIC | 1 | 29 | 56 |
| 392 | PARTICIPANT | 1 | 29 | 56 |
| 393 | REGULATORY | 11 | 29 | 481 |
| 394 | ADENOMAS | 1 | 28 | 30 |
| 395 | ADULTS | 1 | 28 | 31 |
| 396 | BASIS | 5 | 28 | 82 |
| 397 | CELL-DEPLETED | 3 | 28 | 65 |
| 398 | DERMATOMYOSITIS | 5 | 28 | 61 |
| 399 | FEASIBILITY | 4 | 28 | 62 |
| 400 | FOLLICULAR | 1 | 28 | 30 |